×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北... [17]
内容类型
期刊论文 [15]
会议论文 [2]
发表日期
2019 [1]
2018 [3]
2017 [3]
2016 [6]
2015 [3]
2012 [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共17条,第1-10条
帮助
限定条件
专题:中国医学科学院 北京协和医学院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Successful treatment with osimertinib and its subsequent resistance mechanism in a patient with non-small-cell lung cancer harboring acquired EGFR T790M mutation after recovery from AC0010-induced interstitial lung disease
期刊论文
2019, 卷号: 12, 页码: 5545-5549
作者:
Wang, Hanping
;
Zhang, Li
;
Shi, Xiaohua
;
Zhang, Xiaotong
;
Si, Xiaoyan
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2020/01/03
osimertinib
AC0010
interstitial lung disease
resistance mechanism
transformation
large-cell neuroendocrine carcinoma
Cabazitaxel, a novel chemotherapeutic alternative for drug-resistant hepatocellular carcinoma
期刊论文
2018, 卷号: 8, 期号: 7, 页码: 1297-1306
作者:
Chen, Ronggao
;
Cheng, Qiyang
;
Owusu-Ansah, Kwabena Gyabaah
;
Chen, Jun
;
Song, Guanyuan
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/03
Hepatocellular carcinoma
cabazitaxel
acquired resistance
sorafenib
P-gp
Combination TS-1 plus EGFR-tyrosine kinase inhibitors (TKIs) for the treatment of non-small cell lung cancer after progression on first-line or further EGFR-TKIs: A phase II, single-arm trial
期刊论文
2018, 卷号: 9, 期号: 6, 页码: 693-698
作者:
Yang, Lu
;
Yang, Sheng
;
Liu, Yutao
;
Li, Junling
;
Hu, Xingsheng
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2020/01/03
Acquired resistance
EGFR-tyrosine kinase inhibitors
non-small cell lung cancer
phase II study
TS-1
Acquired &ITEGFR&IT L718V mutation mediates resistance to osimertinib in non-small cell lung cancer but retains sensitivity to afatinib
期刊论文
2018, 卷号: 118, 页码: 1-5
作者:
Liu, Yutao
;
Li, Yan
;
Ou, Qiuxiang
;
Wu, Xue
;
Wang, Xiaonan
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/03
EGFR
L718V
Osimertinib
Afatinib
Resistance
NSCLC
The role of long noncoding RNA HOTAIR in the acquired multidrug resistance to imatinib in chronic myeloid leukemia cells
期刊论文
2017, 卷号: 22, 期号: 4, 页码: 208-216
作者:
Wang, Haiying
;
Li, Qian
;
Tang, Shusen
;
Li, Meifang
;
Feng, Anhua
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2020/01/04
Chronic myeloid leukemia
imatinib resistance
long noncoding RNA HOTAIR
PI3K/Akt pathway
MCL-1 Up-Regulation through MAPK Activation Confers Acquired Resistance to BCL-2 Inhibitor ABT-199 in Pre-Clinical AML Models
期刊论文
2017, 卷号: 17, 期号: 10, 页码: S2-S2
作者:
Zhang, Qi
;
Han, Lina
;
Pan, Rongqing
;
Shi, Ce
;
Jeremy, Ryan
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/04
Molecular, biological characterization and drug sensitivity of chidamide-resistant non-small cell lung cancer cells
期刊论文
2017, 卷号: 14, 期号: 6, 页码: 6869-6875
作者:
Luo, Song'e
;
Ma, Kai
;
Zhu, Hongxia
;
Wang, Shuren
;
Liu, Mei
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/04
chidamide
acquired resistance
histone deacetylase 1 degradation
cross-resistant
G2 cell cycle arrest
Adaptive and Acquired Resistance to EGFR Inhibitors Converge on the MAPK Pathway
期刊论文
2016, 卷号: 6, 期号: 8, 页码: 1232-1243
作者:
Ma, Pengfei
;
Fu, Yujie
;
Chen, Minjiang
;
Jing, Ying
;
Wu, Jie
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/04
epidermal growth factor receptor
EGFR
MAPK
Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis
期刊论文
2016, 卷号: 16, 页码: 26
作者:
Gao, Jingtao
;
Ma, Yan
;
Du, Jian
;
Zhu, Guofeng
;
Tan, Shouyong
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/04
Tuberculosis
Multi-Drug Resistant Tuberculosis
Standard Short-Course Chemotherapy
Acquired drug resistant tuberculosis emergence
Upregulation of MAPK/MCL-1 Maintaining Mitochondrial Oxidative Phosphorylation Confers Acquired Resistance to BCL-2 Inhibitor Venetoclax in AML
期刊论文
2016, 卷号: 128, 期号: 22
作者:
Zhang, Qi
;
Han, Lina
;
Shi, Ce
;
Pan, Rongqing
;
Ma, Man Chun John
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/04
©版权所有 ©2017 CSpace - Powered by
CSpace